VAERS reports by lot

GSK Varicella/Shingles lot Y537X: VAERS reports

23 VAERS reports list lot Y537X as a GSK Varicella/Shingles vaccine, received between 2021-12-17 and 2024-02-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
4%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)822%
Neurological719%
Injection-site / Local reaction616%
Cardiac / Cardiovascular514%
Musculoskeletal411%
Gastrointestinal25%
Autoimmune / Immune-mediated13%
Allergic / Anaphylactic13%
Respiratory13%
Dermatological (non-injection-site)13%
Psychiatric / Neuropsychiatric13%

Where reports came from

U.S. state of the reporter, where given (top 11).

District of Columbia9
Florida3
Pennsylvania2
North Carolina1
Rhode Island1
New Jersey1
Nebraska1
Minnesota1
California1
Utah1
Maine1

Reports by month received

2021-122
2022-012
2022-022
2022-032
2022-043
2022-062
2023-123
2024-012
2024-025

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.